Industry
Hospital CEOs Navigate Site-Neutral Payment Pressures Amid Medicaid Changes
Health system CEOs are confronting multiple financial pressures, including Medicaid coverage and reimbursement changes under HR 1, ongoing 340B drug discount program policy challenges, and site-neutral payment considerations. These policy shifts are influencing where health systems invest and deliver care. The article features perspectives from executives at Valley Health and other systems on how they are adapting their care delivery and investment strategies in response to these combined pressures.
Why it mattersSite-neutral payment policies and Medicaid reimbursement changes under HR 1 are forcing health systems to reassess facility-based care investments, which could affect provider network composition and access for Medicaid managed care enrollees.